Author: Vitaliy Dadalyan

These 2 Penny Stocks Are Poised for a Massive Rally, Says Roth Capital

Bull or bear market, no investment is a sure thing. Especially in the current financial environment, which remains riddled with uncertainty, finding compelling plays can be challenging for even the most seasoned market watchers. However, this is not to say that investment opportunities with stand-out growth prospects can’t be found.Roth Capital research analyst Zegbeh Jallah pointed to the healthcare sector, in particular, as an area of the market worthy of investor attention.“Biotech had had a strong performance during the midst of the pandemic, and we expect it to remain so, largely driven by solid fundamental catalysts. This is supported by the resumption of preclinical and clinical efforts at many companies, albeit with some new procedures in place,” Jallah noted.Bearing this in mind, our focus turned to two penny stocks from the healthcare space backed by Roth Capital. Along with the stamp of approval, the firm believes that both of these tickers...

Coronavirus Latest: Monday, September 28

On Monday, Inovio announced that it would be halting its phase 2/3 coronavirus vaccine trial so that it could continue to answer questions from the FDA. This comes as the MidWest of the United States starts to see coronavirus positive cases topping 25%. Yahoo Finance’s Anjalee Khemlani joins The Final Round to discuss the latest on the coronavirus....